{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:27:16Z","timestamp":1772166436474,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:00:00Z","timestamp":1681862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:00:00Z","timestamp":1681862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008750","name":"Shanghai Hospital Development Center","doi-asserted-by":"publisher","award":["SHDC2020CR3028A"],"award-info":[{"award-number":["SHDC2020CR3028A"]}],"id":[{"id":"10.13039\/501100008750","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Type 2 diabetes mellitus (T2DM) with obesity is a glycolipid metabolism disorder, which makes hypoglycaemic treatment more complex and increases the proportion of multidrug combinations. In addition, patients are more prone to adverse reactions and gradually lose compliance with treatment. Previous clinical trials have demonstrated that Daixie Decoction granules (DDG) can reduce body weight and blood lipids and improve the quality of life of T2DM with obesity. But there are a lack of further evaluations for the efficacy and safety of DDG combined with metformin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods\/design<\/jats:title>\n                    <jats:p>\n                      The study is designed as a multicentre, randomized, double-blind, placebo-controlled clinical trial. Participants who meet the Nathrow criteria will be randomly assigned to the intervention group and control group (\n                      <jats:italic>n<\/jats:italic>\n                      <jats:sub>1<\/jats:sub>\n                      \u2009=\u2009\n                      <jats:italic>n<\/jats:italic>\n                      <jats:sub>2<\/jats:sub>\n                      \u2009=\u2009133). Based on a unified diet control and exercise therapy, the intervention group will be treated with DDG and metformin, and the control group will be treated with DDG placebo and metformin. All subjects will receive a 6-month treatment followed by a 6-month follow-up. Effective rate of a 1% decrease in HbA1c and 3% decrease in body weight will serve as the primary outcome. The secondary outcome include fasting plasma glucose, blood lipids, C-peptides, insulin, inflammatory factors, insulin resistance index (HOMA-IR) and the subcutaneous and visceral fat content in the upper abdomen measured by MRI. Blood routine, urine routine, stool routine, liver and kidney function, EKG and other safety indicators and major adverse reactions were monitored during total treatment and follow-up time.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>We aimed to determine the efficacy and safety of DDG combined with metformin for the treatment of T2DM patients with obesity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      Trial registration: ChiCTR, ChiCTR2000036290. Registered 22 August 2014,\u00a0\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.chictr.org.cn\/showprojen.aspx?proj=59001\">http:\/\/www.chictr.org.cn\/showprojen.aspx? proj=59001<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-023-07301-4","type":"journal-article","created":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T16:33:03Z","timestamp":1681921983000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effectiveness and safety of Daixie Decoction granules combined with metformin for the treatment of T2DM patients with obesity: study protocol for a randomized, double-blinded, placebo-controlled, multicentre clinical trial"],"prefix":"10.1186","volume":"24","author":[{"given":"Zhidong","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kepei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianpin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,19]]},"reference":[{"key":"7301_CR1","first-page":"4","volume":"15","author":"Y Mu","year":"2018","unstructured":"Mu Y. Blood glucose fluctuations: new consensus, recognizing. Drug Eval. 2018;15:4\u20137+32.","journal-title":"Drug Eval"},{"key":"7301_CR2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m997","volume":"369","author":"Y Li","year":"2020","unstructured":"Li Y, Teng D, Shi X, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study. BMJ. 2020;369: m997.","journal-title":"BMJ"},{"key":"7301_CR3","first-page":"292","volume":"38","author":"Chinese Diabetes Society","year":"2018","unstructured":"Chinese Diabetes Society. Chinese guidelines for the prevention and treatment of type 2 diabetes. Chin J Pract Intern Med. 2018;38:292\u2013344.","journal-title":"Chin J Pract Intern Med"},{"key":"7301_CR4","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/978-1-4614-5441-0_31","volume":"771","author":"S Schwartz","year":"2012","unstructured":"Schwartz S, Fabricatore A, Diamond A. Weight reduction in diabetes. Adv Exp Med Biol. 2012;771:438\u201358.","journal-title":"Adv Exp Med Biol"},{"key":"7301_CR5","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S2213-8587(16)30244-3","volume":"4","author":"N Sattar","year":"2016","unstructured":"Sattar N, Logue J, Preiss D. Research digest: weight loss to prevent and treat diabetes. Lancet Diabetes Endocrinol. 2016;4:817.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"Suppl 2","key":"7301_CR6","first-page":"41","volume":"22","author":"American College of Cardiology\/American Heart Association Task Force on Practice Guidelines, Obesity Expert Panel","year":"2014","unstructured":"American College of Cardiology\/American Heart Association Task Force on Practice Guidelines, Obesity Expert Panel. Expert panel report: guidelines (2013) for the management of overweight and obesity in adults. Obesity (Silver Spring). 2014;22(Suppl 2):41\u2013410.","journal-title":"Obesity (Silver Spring)"},{"key":"7301_CR7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3810\/pgm.2014.01.2734","volume":"126","author":"ML Vetter","year":"2014","unstructured":"Vetter ML, Amaro A, Volger S. Nutritional management of type 2 diabetes mellitus and obesity and pharmacologic therapies to facilitate weight loss. Postgrad Med. 2014;126:139\u201352.","journal-title":"Postgrad Med"},{"key":"7301_CR8","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1186\/s12967-019-2096-8","volume":"17","author":"H Al-Sulaiti","year":"2019","unstructured":"Al-Sulaiti H, Diboun I, Agha M, et al. Metabolic signature of obesity-associated insulin resistance and type 2 diabetes. J Transl Med. 2019;17:348.","journal-title":"J Transl Med"},{"key":"7301_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/pedi.12787","volume":"20","author":"JI Malone","year":"2019","unstructured":"Malone JI, Hansen BC. Does obesity cause type 2 diabetes mellitus (T2DM)? Or is it the opposite? Pediatr Diabetes. 2019;20:5\u20139.","journal-title":"Pediatr Diabetes"},{"key":"7301_CR10","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41574-020-0381-5","volume":"16","author":"F Magkos","year":"2020","unstructured":"Magkos F, Hjorth MF, Astrup A. Diet and exercise in the prevention and treatment of type 2 diabetes mellitus. Nat Rev Endocrinol. 2020;16:545\u201355.","journal-title":"Nat Rev Endocrinol"},{"key":"7301_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/nutd.2016.16","volume":"6","author":"A Firouzjaei","year":"2016","unstructured":"Firouzjaei A, Li GC, Wang N, et al. Comparative evaluation of the therapeutic effect of metformin monotherapy with metformin and acupuncture combined therapy on weight loss and insulin sensitivity in diabetic patients. Nutr Diabetes. 2016;6: e209.","journal-title":"Nutr Diabetes"},{"key":"7301_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/1741-7015-12-51","volume":"12","author":"AF Macedo","year":"2014","unstructured":"Macedo AF, Taylor FC, Casas JP, et al. Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis. BMC Med. 2014;12:51.","journal-title":"BMC Med"},{"key":"7301_CR13","first-page":"623","volume":"32","author":"Chinese Society of Endocrinology","year":"2016","unstructured":"Chinese Society of Endocrinology. Expert consensus on the management of type 2 diabetes mellitus with obesity in China. Chin J Endocrinol Metab. 2016;32:623\u20137.","journal-title":"Chin J Endocrinol Metab"},{"key":"7301_CR14","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.endinu.2018.10.010","volume":"66","author":"R Reyes-Garc\u00eda","year":"2019","unstructured":"Reyes-Garc\u00eda R, Moreno-P\u00e9rez \u00d3, Tejera-P\u00e9rez C, et al. Document on a comprehensive approach to type 2 diabetes mellitus. Endocrinol Diabetes Nutr. 2019;66:443\u201358.","journal-title":"Endocrinol Diabetes Nutr"},{"key":"7301_CR15","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1586\/14737167.2015.1024661","volume":"15","author":"V Vaidya","year":"2015","unstructured":"Vaidya V, Gangan N, Sheehan J. Impact of cardiovascular complications among patients with type 2 diabetes mellitus: a systematic review. Expert Rev Pharmacoecon Outcomes Res. 2015;15:487\u201397.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"7301_CR16","first-page":"1104","volume":"44","author":"QH Wu","year":"2019","unstructured":"Wu QH, Li BT, Tu J. Compound traditional Chinese medicine in treatment of diabetes. Zhongguo Zhong Yao Za Zhi. 2019;44:1104\u20139.","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"7301_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-024800","volume":"9","author":"J He","year":"2019","unstructured":"He J, Li Z, Huang W, et al. Efficacy and safety of Chou-Ling-Dan granules in the treatment of seasonal influenza via combining Western and traditional Chinese medicine: protocol for a multicentre, randomised controlled clinical trial. BMJ Open. 2019;9: e024800.","journal-title":"BMJ Open"},{"key":"7301_CR18","volume-title":"Sample size calculations in clinical research","author":"SC Chow","year":"2018","unstructured":"Chow SC, Shao J, Wang H, et al. Sample size calculations in clinical research. Boca Raton, FL: Taylor & Francis Group; 2018."},{"key":"7301_CR19","first-page":"517","volume":"26","author":"X Wu","year":"2013","unstructured":"Wu X, Li CJ, Ding BF, et al. Sample size estimation in superiority clinical trials for two means comparison. J Math Med. 2013;26:517\u20139.","journal-title":"J Math Med"},{"key":"7301_CR20","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377\u201381.","journal-title":"J Biomed Inform"},{"key":"7301_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95: 103208.","journal-title":"J Biomed Inform"},{"key":"7301_CR22","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/j.dsx.2019.01.040","volume":"13","author":"M Halim","year":"2019","unstructured":"Halim M, Halim A. The effects of inflammation, aging and oxidative stress on the pathogenesis of diabetes mellitus (type 2 diabetes). Diabetes Metab Syndr. 2019;13:1165\u201372.","journal-title":"Diabetes Metab Syndr"},{"key":"7301_CR23","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/S2213-8587(13)70021-4","volume":"2","author":"W Yang","year":"2014","unstructured":"Yang W, Liu J, Shan Z, et al. Acarbose compared with metformin as initial therapy in patients with newly diagnosed type 2 diabetes: an open-label, non-inferiority randomised trial. Lancet Diabetes Endocrinol. 2014;2:46\u201355.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"7301_CR24","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1007\/s40265-018-1025-0","volume":"78","author":"YE Lentferink","year":"2018","unstructured":"Lentferink YE, Knibbe CAJ, van der Vorst MMJ. Efficacy of metformin treatment with respect to weight reduction in children and adults with obesity: a systematic review. Drugs. 2018;78:1887\u2013901.","journal-title":"Drugs"},{"key":"7301_CR25","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1001\/jama.2011.860","volume":"305","author":"D Preiss","year":"2011","unstructured":"Preiss D, Seshasai SR, Welsh P, et al. Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. JAMA. 2011;305:2556\u201364.","journal-title":"JAMA"},{"key":"7301_CR26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.5551\/jat.13.95","volume":"13","author":"T Takano","year":"2006","unstructured":"Takano T, Yamakawa T, Takahashi M, et al. Influences of statins on glucose tolerance in patients with type 2 diabetes mellitus. J Atheroscler Thromb. 2006;13:95\u2013100.","journal-title":"J Atheroscler Thromb"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07301-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-023-07301-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07301-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T16:33:10Z","timestamp":1681921990000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-023-07301-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,19]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["7301"],"URL":"https:\/\/doi.org\/10.1186\/s13063-023-07301-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-499657\/v1","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,19]]},"assertion":[{"value":"5 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This clinical trial will be conducted in accordance with <i>the Declaration of Helsinki<\/i> and <i>Good Clinical Practice<\/i> and has been approved by the Ethics Committee of Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine (No. 2021LCSY049). All participants must provide informed consent. The results will be disseminated in international medical conferences and peer-reviewed publications.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"283"}}